Search research articles
Contact Us
Filters
Showing results (951-960 of 962) with videos related to
Page
of 97
Sort By:
The New England Journal of Medicine
|
September 1, 2015
Cyclosporine before PCI in Patients with Acute Myocardial Infarction
Thien-Tri Cung, Olivier Morel, Guillaume Cayla, et al.
Journal of the American College of Cardiology
|
April 21, 2020
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Behnood Bikdeli, Mahesh V Madhavan, David Jimenez, et al.
Gastroenterology
|
June 2, 2019
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
Paul Moayyedi, John W Eikelboom, Jackie Bosch, et al.
Gastroenterology
|
May 6, 2019
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial
Paul Moayyedi, John W Eikelboom, Jackie Bosch, et al.
Hepatology International
|
May 19, 2023
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
Xiao-Dong Zhou, Giovanni Targher, Christopher D Byrne, et al.
The New England Journal of Medicine
|
November 12, 2023
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia
Jeffrey L Carson, Maria Mori Brooks, Paul C Hébert, et al.
The New England Journal of Medicine
|
August 29, 2017
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
John W Eikelboom, Stuart J Connolly, Jackie Bosch, et al.
Eclinicalmedicine
|
March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group
Olivier Hermine, Xavier Mariette, Raphael Porcher, et al.
Metabolism: Clinical and Experimental
|
June 9, 2024
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Yehuda Handelsman, John E Anderson, George L Bakris, et al.
The New England Journal of Medicine
|
April 1, 2020
Initial Invasive or Conservative Strategy for Stable Coronary Disease
David J Maron, Judith S Hochman, Harmony R Reynolds, et al.
Page
of 97
Search research articles
Search
Showing results (951-960 of 962) with videos related to
Sort By:
Page
of 97
The New England Journal of Medicine
|
September 1, 2015
Cyclosporine before PCI in Patients with Acute Myocardial Infarction
Thien-Tri Cung, Olivier Morel, Guillaume Cayla, et al.
Journal of the American College of Cardiology
|
April 21, 2020
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Behnood Bikdeli, Mahesh V Madhavan, David Jimenez, et al.
Gastroenterology
|
June 2, 2019
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
Paul Moayyedi, John W Eikelboom, Jackie Bosch, et al.
Gastroenterology
|
May 6, 2019
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial
Paul Moayyedi, John W Eikelboom, Jackie Bosch, et al.
Hepatology International
|
May 19, 2023
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
Xiao-Dong Zhou, Giovanni Targher, Christopher D Byrne, et al.
The New England Journal of Medicine
|
November 12, 2023
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia
Jeffrey L Carson, Maria Mori Brooks, Paul C Hébert, et al.
The New England Journal of Medicine
|
August 29, 2017
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
John W Eikelboom, Stuart J Connolly, Jackie Bosch, et al.
Eclinicalmedicine
|
March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group
Olivier Hermine, Xavier Mariette, Raphael Porcher, et al.
Metabolism: Clinical and Experimental
|
June 9, 2024
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Yehuda Handelsman, John E Anderson, George L Bakris, et al.
The New England Journal of Medicine
|
April 1, 2020
Initial Invasive or Conservative Strategy for Stable Coronary Disease
David J Maron, Judith S Hochman, Harmony R Reynolds, et al.
Page
of 97